Table 3 Sensitivity analysis 1 – Influence of PDC rates on health care expenditures

(Intercept)

− 4388.13

1956.20

−2.24

0.0249*

Age

55 < 65

366.80

667.03

0.55

0.5824

65 < 75

23.96

622.49

0.04

0.9693

≥ 75

− 1479.16

628.26

−2.35

0.0186*

Gender

female

− 182.06

298.09

−0.61

0.5414

BMI

underweight

760.97

1784.07

0.43

0.6697

overweight

−105.89

352.11

−0.30

0.7636

obese

− 177.73

380.95

−0.47

0.6408

BIMD 2010 (Q1 least deprived, Q5 most deprived)

Q2

− 342.96

410.99

− 0.83

0.4040

Q3

−745.28

441.27

−1.69

0.0913

Q4

− 299.33

436.92

−0.69

0.4933

Q5

− 781.20

414.84

−1.88

0.0597

Smoker

yes

−49.90

431.94

−0.12

0.9080

NYHA

1

2580.50

776.13

3.32

0.0009***

2

1378.37

463.25

2.98

0.0029**

3

2809.18

417.38

6.73

0.0000***

4

4422.92

440.04

10.05

0.0000***

DMP COPD

yes

1042.85

498.59

2.09

0.0365*

DMP asthma

yes

− 759.08

841.90

− 0.90

0.3673

DMP diabetes type 1

yes

2033.06

2326.11

0.87

0.3821

DMP diabetes type 2

yes

505.34

276.79

1.83

0.0679

deceased

yes

10,472.27

911.95

11.48

0.0000***

HMG assignments per month

1.23

0.24

5.18

0.0000***

Year after AMI

− 5722.92

162.81

−35.15

0.0000***

days insured

42.73

4.86

8.79

0.0000***

Angina pectoris

2027.02

270.66

7.49

0.0000***

Peripheral vascular disease

4179.64

382.42

10.93

0.0000***

Dyslipidemia

498.35

352.61

1.41

0.1576

Congestive heart failure

2090.90

339.30

6.16

0.0000***

Hypertension

1867.35

556.62

3.35

0.0008***

Dialysis

23,977.62

964.93

24.85

0.0000***

edf

Ref.df

F

p-value

s (PDC mean ACE inhibitors) male

1.04

1.04

0.01

0.9423

s (PDC mean ACE inhibitors) female

1.00

1.00

0.89

0.3465

s (PDC mean β-blockers) male

1.00

1.00

2.70

0.1003

s (PDC mean β-blockers) female

1.00

1.00

0.32

0.5704

s (PDC mean statins) male

1.65

1.65

1.87

0.0949

s (PDC mean statins) female

1.00

1.00

1.61

0.2044

s (PDC mean anti-platelet agents) male

2.49

2.49

18.84

0.0000***

s (PDC mean anti-platelet agents) female

3.38

3.38

6.26

0.0003***

s (PDC standard deviation ACE inhibitors) male

2.35

2.35

1.73

0.1356

s (PDC standard deviation ACE inhibitors) female

2.72

2.72

6.54

0.0005***

s (PDC standard deviation β-blockers) male

3.63

3.63

12.74

0.0000***

s (PDC standard deviation β-blockers) female

1.00

1.00

2.89

0.0893

s (PDC standard deviation statins) male

1.00

1.00

0.43

0.5129

s (PDC standard deviation statins) female

3.58

3.58

3.73

0.0107*

s (PDC standard deviation anti-platelet agents) male

4.05

4.05

4.77

0.0007***

s (PDC standard deviation anti-platelet agents) female

2.79

2.79

4.54

0.0059**